🇺🇸 FDA
Pipeline program

Bilaxten Flas 10 mg comprimidos bucodispersables

BILA-4124/PED

Approved small_molecule active

Quick answer

Bilaxten Flas 10 mg comprimidos bucodispersables for Allergic rhinoconjunctivitis is a Approved program (small_molecule) at A. Menarini Industrie Farmaceutiche Riunite s.r.l. with 1 ClinicalTrials.gov record(s).

Program details

Company
A. Menarini Industrie Farmaceutiche Riunite s.r.l.
Indication
Allergic rhinoconjunctivitis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials